| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Director | Common Stock | 18.5K | $91.7K | $4.96 | Mar 9, 2023 | Direct |
| ZEVRA THERAPEUTICS, INC. | Director | Common Stock | 69 | $342 | $4.96 | Mar 9, 2023 | By TD Ameritrade Clearing Inc. Custodian FBO Matthew Ryan Plooster Roth IRA, as trustee |
| ZEVRA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 49.2K | Apr 25, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ZVRA | ZEVRA THERAPEUTICS, INC. | Apr 25, 2023 | 1 | $0 | 4 | May 8, 2023 | Director |
| ZVRA | ZEVRA THERAPEUTICS, INC. | Mar 9, 2023 | 1 | $46.1K | 4 | Mar 13, 2023 | Director |
| ZVRA | KEMPHARM, INC | Jun 28, 2022 | 1 | $0 | 4 | Jun 30, 2022 | Director |
| ZVRA | KEMPHARM, INC | May 18, 2022 | 4 | $24.8K | 4 | May 18, 2022 | Director |
| ZVRA | KEMPHARM, INC | Dec 1, 2021 | 1 | $21.1K | 4 | Dec 1, 2021 | Director |
| ZVRA | KEMPHARM, INC | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |